Today: 17 June 2026
Rocket Companies steady at $14 as BTIG downgrades, firm refinances debt
16 June 2026
2 mins read

Rocket Companies steady at $14 as BTIG downgrades, firm refinances debt

NEW YORK, June 16, 2026, 16:23 (EDT)

  • Rocket Companies shares were last seen near $13.93, with the stock steady after a choppy session and sticking close to its Monday rebound.
  • BTIG downgraded Rocket to Neutral from Buy, saying most of the platform strength is already priced into the stock.
  • Rocket priced $1.5 billion in senior notes as investors look to Wednesday’s Fed decision and new mortgage-rate moves.

Rocket Companies was steady late Tuesday, sticking close to $14. BTIG cut its rating on the mortgage lender, while traders watched for a debt refinancing set to finish the same day. Shares last changed hands at $13.93, up 0.1%, moving in a range from $13.46 to $14.35 during the day.

Rocket is in focus now as a listed housing-finance stock sensitive to moves in mortgage demand. If rates drop, buyers and homeowners have more incentive to take out new loans or refinance. Demand can slow when rates go up or stay elevated.

BTIG’s Douglas Harter downgraded Rocket, Fannie Mae and Freddie Mac to Neutral from Buy, National Mortgage News said. In his second-half outlook, Harter said higher rates made it clear “the importance of having a balanced business model.” He noted Rocket’s consumer brand, servicing arm, work with Redfin and tech offering as positives, but said the valuation already priced in the “premium nature” of the platform. For the rest of the year, BTIG said it prefers Rithm and UWM Holdings among mortgage stocks. National Mortgage News

The stock paused after climbing Monday. Rocket finished Monday at $13.91, up 6.43%, according to Barron’s market data. Still, shares are far from their 52-week high from January.

Rocket has funding news for investors. In a filing on June 9, the company said it upped the size of its bond deal and priced $1.5 billion in senior notes. The offering is split between $900 million of 6.125% notes due 2031 and $600 million of 6.500% notes due 2034. These bonds stand ahead of junior debt but aren’t backed by specific collateral. Rocket plans to use proceeds to pay back its 2.875% notes due 2026, 5.250% notes due 2028 and other debt. The sale is expected to close June 16, pending usual conditions.

Rocket says it’s putting together a bigger homeownership platform after deals for Redfin and Mr. Cooper. In May, CEO Varun Krishna told investors the company is “not waiting for the market to get easier,” reporting first-quarter revenue of $2.94 billion, net income on a GAAP basis of $297 million, and adjusted EBITDA at $738 million. PR Newswire

Rates haven’t lost their pull on the market. Freddie Mac said the average 30-year fixed mortgage rate hit 6.52% as of June 11. That’s a slight move up from 6.48% the previous week, though lower than 6.84% a year ago. Still, affordability is stretched, even with some relief from last year.

Stocks ended mixed. The Dow closed at another record, its second in a row, while the Nasdaq and S&P 500 were lower, Reuters said. “We’re just digesting some of those gains and the setup in anticipation of the Fed meeting is always a little tentative,” Mark Luschini, chief investment strategist at Janney Montgomery Scott, told Reuters. Reuters

The downside risk is real. The new notes have higher coupons than some of Rocket’s existing debt, so repayment could cost more. If the Fed stays hawkish, mortgage rates may stay high, slowing demand for purchases and refinancing. Evercore ISI’s Krishna Guha said Fed Chair Kevin Warsh faces a tough balance: too hawkish could hit stocks, but leaning dovish could send long yields up.

Rocket now faces the challenge of proving its larger servicing business and the Redfin partnership can help keep results steadier with rates still high. For now, shares are moving less on big news and more on whether scale alone gets a premium from investors before the mortgage cycle shifts.

Stock Market Today

  • Coffee Prices Surge to 5-Week Highs on Brazil Rain Delays and Supply Concerns
    June 16, 2026, 6:44 PM EDT. Coffee prices reached 5-week highs on Tuesday, with Arabica up 5.44% and Robusta rising 1.72%, driven by heavy rain forecasts in Brazil risking harvest delays. Brazil, the world's largest coffee producer, faces persistent rainfall across its coffee regions, supported by a forecast for moderate to heavy rain from Vaisala. ICE Arabica inventories fell to a 6.75-month low, reinforcing supply tightness. Meanwhile, concerns mount over a potential El Niño event, projected to be one of the strongest on record, threatening Brazil's 2026/27 coffee crop with delayed rains during critical flowering months. Despite a USDA forecast of a record 2026/27 Brazil coffee crop of 71.9 million bags, supply risks and tighter shipping conditions caused by the Strait of Hormuz closure bolster prices. Vietnam's rising coffee exports create pressure on Robusta prices, but supply challenges persist for global coffee markets.

Latest articles

Aditxt trades near $0.01 with ADTX filings and Nasdaq delisting risk in focus

Aditxt trades near $0.01 with ADTX filings and Nasdaq delisting risk in focus

17 June 2026
Aditxt shares plunged 17% to $0.0109 amid nearly 929 million shares traded, as Nasdaq delisting risk and uncertainty over the $150 million Ignite Proteomics spin-off overshadowed HRT Financial’s purchase of 4.25 million shares at $0.016; the stock’s fate hinges on compliance and the Ignite deal’s completion.
Sadot Group drops 63% as Nasdaq deadline, deal filings shake investors

Sadot Group drops 63% as Nasdaq deadline, deal filings shake investors

17 June 2026
Sadot Group shares plunged 63.1% to $8.67 after a late-session volatility pause as investors weighed a looming June 22 Nasdaq delisting deadline tied to a stockholders’ equity shortfall, a $125.5 million Los Angeles property option paid with 17.71% of its stock, and ongoing liquidity and default risks.
Pfizer trades up with Rigel’s Veppanu deal done

Pfizer trades up with Rigel’s Veppanu deal done

17 June 2026
Pfizer shares edged up 0.15% to $26.04 after Rigel closed a Veppanu licensing deal with Arvinas and Pfizer, triggering a $35 million payment to Pfizer; the deal highlights ongoing investor focus on whether Pfizer’s oncology and obesity pipeline can offset COVID declines and looming patent losses, with analysts split on pipeline potential versus slow growth and patent pressure.
ARK ramps up SpaceX buys as Musk-led stocks keep rallying
Previous Story

ARK ramps up SpaceX buys as Musk-led stocks keep rallying

T1 Energy Shares Edge Lower Before Shareholder Vote on KORE Power Bid
Next Story

T1 Energy Shares Edge Lower Before Shareholder Vote on KORE Power Bid

Go toTop